Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Med (New York, N.Y.)|July 9, 2022
Patient-centered trials in oncology: Time for a changeDaniel V Araujo, Joao A Soler, Vladmir C Cordeiro de Lima
Frontiers in Immunology|September 12, 2022
Lung cancer in never smokers: Tumor immunology and challenges for immunotherapyViviane Teixeira L de Alencar, Amanda B Figueiredo, Marcelo Corassa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 8, 2021
Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis-the META-L-BRAIN StudyViviane Teixeira Loiola de Alencar, Marcos Pedro Guedes Camandaroba, Rafaela Pirolli, et al.
Jornal Brasileiro De Pneumologia : Publicacao Oficial Da Sociedade Brasileira De Pneumologia E Tisilogia|December 15, 2021
Malignant pleural mesothelioma: an updateGlaucia N M Hajj, Carolina H Cavarson, Clóvis Antônio Lopes Pinto, et al.
BMC Cancer|August 7, 2021
A high CD8 to FOXP3 ratio in the tumor stroma and expression of PTEN in tumor cells are associated with improved survival in non-metastatic triple-negative breast carcinomaMonique C Tavares, Cristina D Sampaio, Geraldine E Lima, et al.
Clinical Lung Cancer|May 11, 2026
Staging Modalities in Non-Small Cell Lung Cancer: Evidence-Based Guideline and Systematic Review by the Brazilian Group of Thoracic OncologyClarissa Baldotto, Eldsamira Mascarenhas, Ana Caroline Zimmer Gelatti, et al.
JCO Global Oncology|March 26, 2026
Systematic Review and Meta-Analysis of Lung Cancer Diagnostic Methods by the Brazilian Thoracic Oncology Group (GBOT)Vladmir C Cordeiro de Lima, Clarissa Baldotto, Eldsamira Mascarenhas, et al.
Scientific Reports|March 22, 2026
Analysis of the NLRP3 inflammasome components expression in triple-negative breast cancer patients with and without BRCA1 mutationsSara Socorro Faria, Susan Costantini, Elena Di Gennaro, et al.
JCO Global Oncology|June 4, 2026
Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non-Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT)Eldsamira Mascarenhas, Clarissa Baldotto, Ana Caroline Z Gelatti, et al.
The Oncologist|March 4, 2025
Real-world characteristics and outcomes of ERBB2-mutant NSCLC in Latin American patients (CLICaP)Erick F Saldanha, Vladmir C Cordeiro de Lima, Aline Fares, et al.
Pageof 3